Webinar: Why Patient-Specific Insulin Dosing Matters. Watch for free today!
Blog
Monarch Commits to National Health IT Week
This week is National Health IT Week.
September 26-30 is dedicated to raising awareness and recognizing the value of health IT in innovation, expanding access to care, expansion of economic opportunities and job creation, and making communities healthy.
The team at Monarch Medical Technologies is using each day this week to describe one of the five ways we are committed to this mission.
- Managing Glucose Monday. EndoTool Glucose Management System provides a personalized insulin dose recommendation by using more than 60 algorithms. The software models each patient’s individual response to insulin and predicts the next blood glucose reading, making the software the safest option on the market.
- Timely Control Tuesday. EndoTool applications specialize in some of the most difficult patient scenarios (DKA, HNS, etc.) and provides a safe and efficient solution for glucose management with 99.4% of all patients achieving control.
- Workflow Wednesday. The integration of EndoTool is seamless into the organization’s existing IT infrastructure. The EndoTool EMR application is compatible with all the major Electronic Medical Record (EMR) systems and reduces duplicative data entry.
- Transitioning Safely Thursday. Transitioning a patient from intravenous insulin to subcutaneous insulin therapy is safe and easy when you are using the software to provide patient specific orders. The transition is smooth and reliable with the click of a button.
- FDA Friday. Monarch’s EndoTool Glucose Management System received multiple FDA clearances (EndoTool IV and EndoTool SubQ) as a Class ll medical device.
Related posts

Blog
Tackling Euglycemic DKA: How EndoTool’s New Mode of Therapy Gives Hospitals a Critical Advantage
Tackling Euglycemic DKA: How EndoTool’s New Mode of Therapy Gives Hospitals a Critical Advantage
Hyperglycemic emergencies are becoming increasingly complex to treat, particularly with the rising incidence of Euglycemic Diabetic Ketoacidosis (EuDKA). Often linked to the use of SGLT-2 inhibitors, EuDKA requires a treatment approach that traditional diabetic ketoacidosis (DKA) protocols were not designed ...

Blog
Celebrating Our 2025 Customer of the Year: Atrium Health
Celebrating Our 2025 Customer of the Year: Atrium Health
One of the things I value most as CEO is working with partners who share our passion for making a genuine difference in patient care. This year, I'm proud to share that our inaugural Customer of the Year is Atrium ...

Blog
5 Things Every CNO Should Know About Patient-Specific Insulin Dosing
5 Things Every CNO Should Know About Patient-Specific Insulin Dosing
As a former Director of Nursing and now the leader of a national team focused on implementing a clinical decision support tool for glycemic management, I have had the unique opportunity to guide health systems through the operational and clinical ...
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields